Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I–III Triple-Negative Breast Cancer

被引：0
|
作者：
Carolyn Hall
Mandar Karhade
Barbara Laubacher
Amber Anderson
Henry Kuerer
Sarah DeSynder
Anthony Lucci
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology, Unit 444
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Overall Survival; Circulate Tumor Cell; Axillary Lymph Node Status; Primary Tumor Size; TNBC Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：552 / 558
页数：6
相关论文
共 50 条
  • [41] Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    da Silva, Jesse Lopes
    de Albuquerque, Lucas Zanetti
    Rodrigues, Fabiana Resende
    de Mesquita, Guilherme Gomes
    Fernandes, Priscila Valverde
    Thuler, Luiz Claudio Santos
    de Melo, Andreia Cristina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
    Orozco, Javier I. J.
    Grumley, Janie G.
    Matsuba, Chikako
    Manughian-Peter, Ayla O.
    Chang, Shu-Ching
    Chang, Grace
    Gago, Francisco E.
    Salomon, Matthew P.
    Marzese, Diego M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3185 - 3193
  • [43] Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy
    Ilie, Silvia Mihaela
    Briot, Nathalie
    Constatin, Guillaume
    Ilie, Alis
    Beltjens, Francoise
    Ladoire, Sylvain
    Desmoulins, Isabelle
    Hennequin, Audrey
    Bertaut, Aurelie
    Coutant, Charles
    Causeret, Sylvain
    Ghozali, Niama
    Coudert, Bruno
    Arnould, Laurent
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [44] Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
    Javier I. J. Orozco
    Janie G. Grumley
    Chikako Matsuba
    Ayla O. Manughian-Peter
    Shu-Ching Chang
    Grace Chang
    Francisco E. Gago
    Matthew P. Salomon
    Diego M. Marzese
    Annals of Surgical Oncology, 2019, 26 : 3185 - 3193
  • [45] Tumour residue after neoadjuvant chemotherapy for triple-negative or Her 2+breast cancer
    El Karroumi, Mohammed
    Benhessou, Mustapha
    Ennachit, Simohammed
    Bencherifi, Younes
    Fadil, Kaoutar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A142 - A142
  • [46] Analysis of circulating tumor cells for monitoring treatment response in triple-negative breast cancer
    Ramirez, Arturo
    Campton, Daniel
    Mahen, Elisabeth
    Blau, C. Anthony
    Kaldjian, Eric Peter
    Stilwell, Jackie L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
    Abreu, Manuel
    Cabezas-Sainz, Pablo
    Pereira-Veiga, Thais
    Falo, Catalina
    Abalo, Alicia
    Morilla, Idoia
    Curiel, Teresa
    Cueva, Juan
    Rodriguez, Carmela
    Varela-Pose, Vanesa
    Lago-Leston, Ramon
    Mondelo, Patricia
    Palacios, Patricia
    Moreno-Bueno, Gema
    Cano, Amparo
    Garcia-Caballero, Tomas
    Angel Pujana, Miquel
    Sanchez-Pinon, Laura
    Costa, Clotilde
    Lopez, Rafael
    Muinelo-Romay, Laura
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [48] Transcriptomic changes in invasive residual cancer after neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Orozco, Javier
    Manughian-Peter, Ayla
    Gago, Francisco
    Chang, Grace
    Grumley, Janie
    Marzese, Diego
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 23 - 24
  • [49] Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy
    Sohn, J.
    Do, K. A.
    Liu, S.
    Chen, H.
    Mills, G. B.
    Hortobagyi, G. N.
    Meric-Bernstam, F.
    Gonzalez-Angulo, A. M.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2522 - 2526
  • [50] Pathologic and immunohistochemical prognostic score in residual triple-negative breast cancer after neoadjuvant chemotherapy
    Ilie, S. M.
    Arnould, L.
    Briot, N.
    Desmoulins, I.
    Hennequin, A.
    Kaderbhai, C.
    Bertaut, A.
    Coutant, C.
    Causeret, S.
    Loustalot, C.
    Ilie, A.
    Derangere, V.
    Ladoire, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S432 - S432
12345